<?xml version="1.0" encoding="UTF-8"?>
<p id="para0029">If the COVID-19 infection is diagnosed after the stem cell infusion, then it should be treated symptomatically and/or on a clinical trial, taking the possibility of manageable drug interferences into account (
 <xref rid="tbl0001" ref-type="table">Table 1</xref>).
</p>
